PRODUCT DETAIL

Everolimus Sandoz 2,5 mg

Code

1193D

MA number

44/0107/19-S

Product Form:

tbl 90x2,5 mg (blis.Al/PA/Al/PVC)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Sandoz Pharmaceuticals d.d., Slovenia

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02	Everolimus

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	16.04.2019
SPC:	SPC_Everolimus Sandoz 2,5 mg_01.2023.pdf
PIL:	PIL_Everolimus Sandoz 2,5 mg_09.2024.pdf
Safety feature	Yes
Data update:	12.07.2023